Ritesh Rathore is an Oncology physician affiliated with Roger Williams Medical Center. OpenAlex indexes 90 publications with 1,339 citations (h-index 16).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
825 Chalkstone Ave
Providence, RI 029084728
Telephone
401-456-2077Registry record last updated 8 Jul 2007.
Industry payments
14 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Deciphera Pharmaceuticals Inc.Program year20256 payments
- Janssen Biotech, Inc.Program year20254 payments
- Exelixis Inc.Program year20252 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
33.1%Kinase inhibitor11%Imatinib Mesylate30%Brukinsa28%Jakafi17%Imbruvica13%Everolimus11%Part D<11 patientsCytochrome P450 17A1 Inhibitor6.9%Abiraterone Acetate100%Part D<11 patients+ 5 more classes in this area
Metabolism & gastrointestinal
25.8%Corticosteroid9.1%Prednisone100%Part D≥15 patientsProton pump inhibitor6%Omeprazole70%Pantoprazole Sodium30%Part D<11 patients+ 3 more classes in this area
Blood & clotting
11.8%Factor Xa inhibitor11.8%Eliquis100%Part D≥14 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- POSTER: CT-552 A Case of Parasitic Infection in Patient Undergoing Stem Cell Transplant
Clinical Lymphoma Myeloma & Leukemia
2023 - TCL-224: Not All Pancreatic Masses Are Pancreatic Adenocarcinomas
Clinical Lymphoma Myeloma & Leukemia
2021 - Age-dependent overall survival benefit of androgen deprivation therapy for metastatic prostate cancer
Journal of Oncology Pharmacy Practice
2019
Similar KOLs
Other experts from the same institution or the same specialty.
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”